|
Sun Pharma Advanced Research Company Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
4564.72 Cr.
|
P/BV
|
-58.99
|
Book Value (Rs.)
|
-2.38
|
|
52 Week High/Low (Rs.)
|
258/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR |
| FaceValue | 1.00 | 1.00 |
| | | |
| | | |
| INCOME | | |
| Revenue From Operations [Net] | 75.55 | 238.78 |
| Total Operating Revenues | 75.55 | 238.78 |
| | | |
| Other Income | 29.47 | 10.88 |
| Total Revenue | 105.01 | 249.66 |
| | | |
| EXPENSES | | |
| Cost Of Materials Consumed | 28.13 | 22.11 |
| Operating And Direct Expenses | 253.81 | 281.41 |
| Employee Benefit Expenses | 141.84 | 107.00 |
| Finance Costs | 1.69 | 7.63 |
| Depreciation And Amortisation Expenses | 12.51 | 11.77 |
| Other Expenses | 53.87 | 42.31 |
| Total Expenses | 491.85 | 472.24 |
| | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -386.83 | -222.58 |
| | | |
| Profit/Loss Before Tax | -386.83 | -222.58 |
| | | |
| Tax Expenses-Continued Operations | | |
| Current Tax | 1.63 | 0.00 |
| Deferred Tax | -1.25 | 0.00 |
| Total Tax Expenses | 0.38 | 0.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -387.21 | -222.58 |
| | | |
| Profit/Loss From Continuing Operations | -387.21 | -222.58 |
| | | |
| Profit/Loss For The Period | -387.21 | -222.58 |
| Consolidated Profit/Loss After MI And Associates | -387.21 | -222.58 |
| | | |
| OTHER INFORMATION | | |
| | | |
| EARNINGS PER SHARE | | |
| Basic EPS (Rs.) | -11.93 | -7.82 |
| Diluted EPS (Rs.) | -11.93 | -7.82 |
